BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 14656025)

  • 1. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
    Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
    Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.
    Weiss N
    Curr Drug Metab; 2005 Feb; 6(1):27-36. PubMed ID: 15720205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
    Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
    Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
    Papatheodorou L; Weiss N
    Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
    Stanger O; Weger M
    Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation.
    Qiu LH; Xie XJ; Zhang BQ
    Biol Pharm Bull; 2010; 33(4):641-6. PubMed ID: 20410599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice.
    Weiss N; Heydrick S; Zhang YY; Bierl C; Cap A; Loscalzo J
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):34-41. PubMed ID: 11788458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.
    Dayal S; Lentz SR
    Antioxid Redox Signal; 2007 Nov; 9(11):1899-909. PubMed ID: 17822370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelial dysfunction in patients with primary hypertension and hyperhomocysteinemia].
    Baszczuk A; Kopczyński Z; Thielemann A
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():91-100. PubMed ID: 24491900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
    Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
    J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries.
    Ramaswami G; Chai H; Yao Q; Lin PH; Lumsden AB; Chen C
    J Vasc Surg; 2004 Dec; 40(6):1216-22. PubMed ID: 15622377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia.
    Dayal S; Blokhin IO; Erger RA; Jensen M; Arning E; Stevens JW; Bottiglieri T; Faraci FM; Lentz SR
    PLoS One; 2014; 9(9):e107734. PubMed ID: 25226386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease.
    Moat SJ; Bonham JR; Powers HJ
    Clin Sci (Lond); 2001 Jan; 100(1):73-9. PubMed ID: 11115421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and glutathione peroxidase-1.
    Lubos E; Loscalzo J; Handy DE
    Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction.
    Liu DS; Gao W; Liang ES; Wang SL; Lin WW; Zhang WD; Jia Q; Guo RC; Zhang JD
    Eur J Pharmacol; 2013 Aug; 714(1-3):163-9. PubMed ID: 23792140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.
    Weiss N; Keller C; Hoffmann U; Loscalzo J
    Vasc Med; 2002 Aug; 7(3):227-39. PubMed ID: 12553746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.